Evidence map›Paper›PMID 24800858›Full record

ArticleJournal of medical Internet research2014

Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse.

Emily C McNaughton, Paul M Coplan, Ryan A Black, Sarah E Weber, Howard D Chilcoat, Stephen F Butler

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Emily C McNaughtonInflexxion, Inc., Newton, MA, United States. emcnaughton@inflexxion.com.
Paul M Coplan
Ryan A Black
Sarah E Weber
Howard D Chilcoat
Stephen F Butler
Inflexxion (United States) · USNova Southeastern University · USPurdue Pharma (United States) · USUniversity of Pennsylvania · US

Funding

Internet Monitoring Of Prescription Drug AbuseR44DA020279 · NIDA · INFLEXXION, INC. · PI BUTLER, STEPHEN F · 2008 to 2010
$810k
Internet Monitoring Of Prescription Drug AbuseR43DA020279 · NIDA · INFLEXXION, INC. · PI BUTLER, STEPHEN F · 2006 to 2006
$150k
NIDA NIH HHS DA020279NIDA NIH HHS R43 DA020279NIDA NIH HHS R44 DA020279
6 · The paper itself

Abstract

backgroundReformulating opioid analgesics to deter abuse is one approach toward improving their benefit-risk balance. To assess sentiment and attempts to defeat these products among difficult-to-reach populations of prescription drug abusers, evaluation of posts on Internet forums regarding reformulated products may be useful. A reformulated version of OxyContin (extended-release oxycodone) with physicochemical properties to deter abuse presented an opportunity to evaluate posts about the reformulation in online discussions.

objectiveThe objective of this study was to use messages on Internet forums to evaluate reactions to the introduction of reformulated OxyContin and to identify methods aimed to defeat the abuse-deterrent properties of the product.

methodsPosts collected from 7 forums between January 1, 2008 and September 30, 2013 were evaluated before and after the introduction of reformulated OxyContin on August 9, 2010. A quantitative evaluation of discussion levels across the study period and a qualitative coding of post content for OxyContin and 2 comparators for the 26 month period before and after OxyContin reformulation were conducted. Product endorsement was estimated for each product before and after reformulation as the ratio of endorsing-to-discouraging posts (ERo). Post-to-preintroduction period changes in ERos (ie, ratio of ERos) for each product were also calculated. Additionally, post content related to recipes for defeating reformulated OxyContin were evaluated from August 9, 2010 through September 2013.

resultsOver the study period, 45,936 posts related to OxyContin, 18,685 to Vicodin (hydrocodone), and 23,863 to Dilaudid (hydromorphone) were identified. The proportion of OxyContin-related posts fluctuated between 6.35 and 8.25 posts per 1000 posts before the reformulation, increased to 10.76 in Q3 2010 when reformulated OxyContin was introduced, and decreased from 9.14 in Q4 2010 to 3.46 in Q3 2013 in the period following the reformulation. The sentiment profile for OxyContin changed following reformulation; the post-to-preintroduction change in the ERo indicated reformulated OxyContin was discouraged significantly more than the original formulation (ratio of ERos=0.43, P<.001). A total of 37 recipes for circumventing the abuse-deterrent characteristics of reformulated OxyContin were observed; 32 were deemed feasible (ie, able to abuse). The frequency of posts reporting abuse of reformulated OxyContin via these recipes was low and decreased over time. Among the 5677 posts mentioning reformulated OxyContin, 825 posts discussed recipes and 498 reported abuse of reformulated OxyContin by such recipes (41 reported injecting and 128 reported snorting).

conclusionsAfter introduction of physicochemical properties to deter abuse, changes in discussion of OxyContin on forums occurred reflected by a reduction in discussion levels and endorsing content. Despite discussion of recipes, there is a relatively small proportion of reported abuse of reformulated OxyContin via recipes, particularly by injecting or snorting routes. Analysis of Internet discussion is a valuable tool for monitoring the impact of abuse-deterrent formulations.

Indexed as

InternetAcetaminophenAnalgesics, OpioidChemistry, PharmaceuticalDrug CombinationsHumansHydrocodoneHydromorphoneOpioid-Related DisordersOxycodoneSocial MediaAcetaminophenacetaminophen, hydrocodone drug combinationAnalgesics, OpioidDrug CombinationsHydrocodoneHydromorphoneOxycodonedrug abuseepidemiologyInternetopioid analgesicOxyContinprescription drugqualitative researchsocial mediasurveillance

Identifiers

PMID24800858
PMCPMC4026575
OpenAlexW2096120909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.